{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:00:06Z","timestamp":1776916806371,"version":"3.51.2"},"reference-count":48,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>On the basis of fungal involvement, rhinosinusitis is categorized into allergic, mycetoma, chronic, and acute invasive types. The aim of the current study was to evaluate the efficacy of an amphotericin gel in situ loaded with nanotransferosomes against Aspergillus flavus, which causes allergic rhinosinusitis. A Box\u2013Behnken design was utilized to study the interaction among the nanotransferosomes and optimize independent variables in formulating them, in order to match the prerequisites of selected responses. The optimal formulation was determined to be 300 mg\/mL soybean lecithin, 200 mg\/mL amphotericin B (AMP), and 150 mg\/mL clove oil, resulting in a particle size of 155.09 nm, 84.30% entrapment efficacy (EE), inhibition zone of 16.0 mm, and 0.1197 mmol serum creatinine. The optimized batch was further prepared into an in situ gel and evaluated for various parameters. The optimized formulation released 79.25% AMP and enhanced permeation through the nasal membrane, while the other formulations did not achieve complete absorption. According to in vivo tests using rabbits as animal models, the optimized AMP-nanotransferosomal formulations (NT) in in situ gel result in a non-significant difference among the various kidney function parameters. In conclusion, nasal in situ gel loaded with AMP-clove oil nanotreansfersomes can act as a promising novel carrier that enhances antifungal activity and decreases AMP nephrotoxicity.<\/jats:p>","DOI":"10.3390\/pharmaceutics13010035","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T10:33:56Z","timestamp":1609151636000},"page":"35","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nasal Gel Loaded with Amphotericin Nanotransferosomes as Antifungal Treatment for Fungal Sinusitis"],"prefix":"10.3390","volume":"13","author":[{"given":"Khaled M.","family":"Hosny","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia"},{"name":"Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3826-1519","authenticated-orcid":false,"given":"Nabil A.","family":"Alhakamy","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia"},{"name":"Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1439-0507.1999.tb00010.x","article-title":"Fungal colonization of the paranasal sinuses","volume":"42","author":"Vennewald","year":"1999","journal-title":"Mycoses"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00405-002-0547-x","article-title":"Allergic Aspergillus flavus rhinosinusitis: A case report from Qatar","volume":"260","author":"Hilal","year":"2003","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0030-6665(00)80011-0","article-title":"Unusual fungal pathogens in fungal rhinosinusutis","volume":"33","author":"Schell","year":"2000","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0030-6665(00)80014-6","article-title":"Allergic fungal rhinosinusitis","volume":"33","author":"Houser","year":"2000","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0030-6665(00)80004-3","article-title":"Histopathology of fungal rhinosinusitis","volume":"33","author":"Schell","year":"2000","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Hope, Liposomal amphotericin B (AmBisome\u00ae): A review of the pharmacokinet-ics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1021\/bm050747n","article-title":"Impact of Aldehyde Content on Amphotericin B\u2212Dextran Imine Conjugate Toxicity","volume":"7","author":"Domb","year":"2006","journal-title":"Biomacromolecules"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s11095-009-9973-4","article-title":"Preparation, Characterization and Evaluation of Targeting Potential of Amphotericin B-Loaded Engineered PLGA Nanoparticles","volume":"26","author":"Nahar","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2006.08.013","article-title":"Formulation and characterization of amphotericin B\u2013chitosan\u2013dextran sulfate nanoparticles","volume":"329","author":"Tiyaboonchai","year":"2007","journal-title":"Int. J. Pharm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpb.2014.11.019","article-title":"Th-1 biased immunomodulation and synergistic antileishmanial activity of stable cationic lipid\u2013 polymer hybrid nanoparticle: Biodistribution and toxicity assess-ment of encapsulated amphotericin B","volume":"89","author":"Asthana","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00522-6","article-title":"Ligand directed macrophage targeting of amphotericin B loaded lipo-somes","volume":"210","author":"Vyas","year":"2000","journal-title":"Int. J. Pharm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jbm.a.31504","article-title":"Amphotericin B-loaded poly (ethylene glycol)\u2013 poly (lactide) micelles: Prepa-ration, freeze-drying, and in vitro release","volume":"85","author":"Yang","year":"2008","journal-title":"J. Biomed. Mater. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.colsurfb.2015.07.032","article-title":"Topical Amphotericin B solid lipid nanoparticles: Design and development","volume":"139","author":"Butani","year":"2016","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.nano.2014.11.008","article-title":"Characterization and evaluation of amphotericin B loaded MDP conju-gated poly (propylene imine) dendrimers","volume":"11","author":"Jain","year":"2015","journal-title":"Nanomedicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0731-7085(00)00499-4","article-title":"Determination of amphotericin B in human plasma using solid-phase extraction and high-performance liquid chromatography","volume":"25","author":"Eldem","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/14737167.2016.1202766","article-title":"Cost-effectiveness of caspofunging versus liposomal ampho-tericin B in the treatment of systemic fungal infections: A systematic review of economic analyses","volume":"16","author":"Mistro","year":"2016","journal-title":"Expert Rev. Phar-Macoecon. Outcomes Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1128\/AAC.48.3.1047-1050.2004","article-title":"Comparative efficacies of four amphotericin B formulations\u2014Fungizone, amphotec (amphocil), ambisome, and abelcet\u2014Against systemic murine aspergillosis","volume":"48","author":"Clemons","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ps.1712","article-title":"Nanodisks protect amphotericin B from ultraviolet light and oxida-tion-induced damage","volume":"65","author":"Tufteland","year":"2009","journal-title":"Pest Manag. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0378-8741(02)00205-2","article-title":"Evaluation of natural products on inhibition of inducible cy-clooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells","volume":"83","author":"Hong","year":"2002","journal-title":"J. Ethnopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1081\/DDC-120028715","article-title":"Formulation and evaluation of mucoadhesive tablets contain-ing eugenol for the treatment of periodontal diseases","volume":"30","author":"Jadhav","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_21","first-page":"19","article-title":"Permeation enhancer for TDDS from natural and synthetic sources: A review","volume":"2","author":"Goswami","year":"2013","journal-title":"J. Biomed. Pharm. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2012.08.009","article-title":"Nanocarriers for topical administration of resveratrol: A comparative study","volume":"440","author":"Scognamiglio","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijpharm.2012.07.003","article-title":"Preparation and quality assessment of itraconazole transfersomes","volume":"436","author":"Zheng","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijpharm.2013.07.031","article-title":"Nano-transfersomes as a novel carrier for transdermal delivery","volume":"454","author":"Chaudharya","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_25","first-page":"140","article-title":"Design expert supported mathematical optimization of repaglinide gastrore-tentive floating tablets: In vitro and in vivo evaluation, Future","volume":"3","author":"Naveen","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1039\/c2sm06463d","article-title":"Hyaluronic acid-based hydrogels: From a natural polysaccharide to complex networks","volume":"8","author":"Xu","year":"2012","journal-title":"Soft Matter."},{"key":"ref_27","first-page":"148","article-title":"Controlled release of injectable liposomal in situ gel loaded with recombinant human bone morphogenetic protein-2 for the repair of alveolar bone clefts in rabbits","volume":"26","author":"Hassan","year":"2016","journal-title":"J. Liposome Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Qushawy, M., Nasr, A., Abd-Alhaseeb, M., and Swidan, S.A. (2018). Design, Optimization and Characterization of a Transfersomal Gel Using Miconazole Nitrate for the Treatment of Candida Skin Infections. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10010026"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhazmat.2009.07.025","article-title":"Application of Box\u2013Behnken design in the optimization of a magnetic nanoparticle procedure for zinc determination in analytical samples by inductively coupled plasma optical emission spectrometry","volume":"172","author":"Khajeh","year":"2009","journal-title":"J. Hazard. Mater."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0378-5173(99)00361-0","article-title":"Lecithin vesicular carriers for transdermal delivery of cyclosporin A","volume":"194","author":"Guo","year":"2000","journal-title":"Int. J. Pharm."},{"key":"ref_31","first-page":"1123","article-title":"Skin delivery from ultradeformable liposomes: Refinement of surfac-tant concentration","volume":"51","author":"Maghraby","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.carbpol.2011.09.065","article-title":"Thiolated pectin nanoparticles: Preparation, characterization and ex vivo corneal permeation study","volume":"87","author":"Sharma","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ijbiomac.2014.08.051","article-title":"Psyllium arabinoxylan: Carboxymethylation, characterization and evaluation for nanopartic-ulate drug delivery","volume":"72","author":"Bhatia","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1567201813666151109102718","article-title":"Co-Delivery of Atorvastatin Nanocrystals in PLGA based in situ Gel for An-ti-Hyperlipidemic Efficacy","volume":"13","author":"Kurakula","year":"2015","journal-title":"Curr. Drug Deliv."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hosny, K.M., Rizg, W.Y., and Khallaf, R.A. (2020). Preparation and Optimization of In Situ Gel Loaded with Rosuvastatin-Ellagic Acid Nanotransfersomes to Enhance the Anti-Proliferative Activity. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030263"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1208\/s12249-011-9678-y","article-title":"Formulation and evaluation of in situ gelling systems for intranasal admin-istration of gastrodin","volume":"12","author":"Tornesello","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bmc.102","article-title":"Development of a chromatographic method for the determination of saquinavir in plasma samples of HIV patients","volume":"16","author":"Campanero","year":"2001","journal-title":"Biomed. Chrom."},{"key":"ref_38","first-page":"33","article-title":"Nephrotoxicity of cefepime a new cephalosporin antibi-otic in rats","volume":"5","author":"Elsayed","year":"2014","journal-title":"J. Pharmacol. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10847-009-9605-y","article-title":"Encapsulation of cyclodextrin complexed simvastatin in chitosan nanocarriers: A novel technique for oral delivery","volume":"66","author":"Vyas","year":"2009","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kurakula, M., and Naveen, N.R. (2020). In Situ Gel Loaded with Chitosan-Coated Simvastatin Nanoparticles: Promising Delivery for Effective Anti-Proliferative Activity against Tongue Carcinoma. Mar. Drugs, 18.","DOI":"10.3390\/md18040201"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1208\/s12249-019-1496-7","article-title":"Preparation, Optimization, and Evaluation of Hyaluronic Acid-Based Hydrogel Loaded with Miconazole Self-Nanoemulsion for the Treatment of Oral Thrush","volume":"20","author":"Hosny","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3109\/08982104.2015.1117490","article-title":"Solid lipid nanoparticles for transdermal delivery of avanafil: Optimization, formulation, in-vitro and ex-vivo studies","volume":"26","author":"Kurakula","year":"2016","journal-title":"J. Liposome Res."},{"key":"ref_43","first-page":"5","article-title":"Etoposide-loaded na-noparticles made from poly-e-caprolactone (PCL): Formulation, characterization, in vitro drug release for controlled drug delivery system","volume":"5","author":"Mallamma","year":"2014","journal-title":"Int. J. Biopharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.foodchem.2019.03.112","article-title":"Optimization of soya lecithin and Tween 80 based novel vitamin D nanoemulsions prepared by ultrasonication using response surface methodology","volume":"289","author":"Tahir","year":"2019","journal-title":"Food Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1517\/17425247.2014.912212","article-title":"Sildenafil citrate as oral solid lipid nanoparticles: A novel formula with higher bioavaila-bility and sustained action for treatment of erectile dysfunction","volume":"11","author":"Hosny","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2014.08.064","article-title":"Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: Preparation, characterization, and in vivo evaluation","volume":"475","author":"Hosny","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2478\/v10007-007-0025-5","article-title":"Design, development and evaluation of novel nanoemulsion formula-tions for transdermal potential of celecoxib","volume":"57","author":"Baboota","year":"2007","journal-title":"Acta Pharm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jddst.2018.02.016","article-title":"Solid lipid nanoparticles of Vancomycin loaded with Ellagic acid as a tool for overcoming nephrotoxic side effects: Preparation, characterization, and nephrotoxicity evaluation","volume":"45","author":"Aldawsari","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/1\/35\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:47:01Z","timestamp":1760179621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/1\/35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,28]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["pharmaceutics13010035"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13010035","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,28]]}}}